$MET Income Statement | Understand Stock

$MET

$100.04 +$1.22 (1.23%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Premiums
Universal life and investment-type product policy fees
Net investment income
Other revenues
Net investment gains (losses)
Net derivative gains (losses)
Total revenues
Expenses
Policyholder benefits and claims
Policyholder liability remeasurement (gains) losses
Market risk benefit remeasurement (gains) losses
Interest credited to policyholder account balances
Policyholder dividends
Other expenses
Total expenses
Income (loss) before provision for income tax
Provision for income tax expense (benefit)
Net income (loss)
Less: Net income (loss) attributable to noncontrolling interests
Net income (loss) attributable to MetLife, Inc.
Less: Preferred stock dividends
Preferred Stock Redemption Premium
Net income (loss) available to MetLife, Inc.’s common shareholders
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:
Basic
Diluted

Comments